IP Library Granted Patent US 9,931,320
Granted Patent B2
US 9,931,320 · App. 14/977,680 · Granted Apr 3, 2018

Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof

Inventors: Mark David Soll (Alpharetta, GA); Diane Larsen (Buford, GA); Susan Mancini Cady (Yardley, PA); Peter Cheifetz (East Windsor, NJ); Izabela Galeska (Newtown, PA); Saijun Gong (Bridgewater, NJ)
Assignee: MERIAL INC.
A61K31/42A01N43/80A23K20/00A61K9/0056A61K9/0068A61K31/194A61K31/27A61K31/325A61K31/365A61K31/437A61K31/4985A61K31/7048A61K45/06A61K47/10A61K47/12A61K47/14A61K47/32A61K47/36A61K47/42A61K47/44C07D261/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,931,320
App. No.
14/977,680
Granted
Apr 3, 2018
Kind
B2
Abstract

This invention relates to oral veterinary compositions for combating ectoparasites and endoparasites in animals, comprising at least one systemically-acting active agent in combination with a pharmaceutically acceptable carrier. This invention also provides for improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.

Claims (661)

1. A method for the treatment and/or prevention of a parasitic infestation and/or infection in an animal comprising administering to the animal an effective amount of a soft chewable veterinary composition comprising:

at least one isoxazoline active agent of Formula (I):

wherein:

A 1 , A 2 , A 3 , A 4 , A 5 and A 6 are independently selected from the group consisting of CR 3 and N, provided that at most 3 of A 1 , A 2 , A 3 , A 4 , A 5 and A 6 are N;

B 1 , B 2 and B 3 are independently selected from the group consisting of CR 2 and N;

W is O or S;

R 1 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C 4 -C 7 alkylcycloalkyl or C 4 -C 7 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R 6 ;

each R 2 is independently H, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 1 -C 6 alkylthio, C 1 -C 6 haloalkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkylsulfonyl, C 1 -C 6 alkylamino, C 2 -C 6 dialkylamino, C 2 -C 4 alkoxycarbonyl, —CN or —NO 2 ;

each R 3 is independently H, halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 3 -C 6 cycloalkyl, C 3 -C 6 halocycloalkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 1 -C 6 alkylthio, C 1 -C 6 haloalkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkylsulfonyl, C 1 -C 6 alkylamino, C 2 -C 6 dialkylamino, —CN or —NO 2 ;

R 4 is H, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C 4 -C 7 alkylcycloalkyl, C 4 -C 7 cycloalkylalkyl, C 2 -C 7 alkylcarbonyl or C 2 -C 7 alkoxycarbonyl;

R 5 is H, OR 10 , NR 11 R 12 or Q 1 ; or C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C 4 -C 7 alkylcycloalkyl or C 4 -C 7 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R 7 ; or

R 4 and R 5 are taken together with the nitrogen to which they are attached to form a ring containing 2 to 6 atoms of carbon and optionally one additional N, S or O atom, said ring optionally substituted with 1 to 4 substituents independently selected from the group consisting of C 1 -C 2 alkyl, halogen, —CN, —NO 2 and C 1 -C 2 alkoxy;

each R 6 is independently halogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 alkylsulfonyl, —CN or —NO 2 ;

each R 7 is independently halogen; C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 alkylamino, C 2 -C 8 dialkylamino, C 3 -C 6 cycloalkylamino, C 2 -C 7 alkylcarbonyl, C 2 -C 7 alkoxycarbonyl, C 2 -C 7 alkylaminocarbonyl, C 3 -C 9 dialkylaminocarbonyl, C 2 -C 7 haloalkylcarbonyl, C 2 -C 7 haloalkoxycarbonyl, C 2 -C 7 haloalkylaminocarbonyl, C 3 -C 9 dihaloalkylaminocarbonyl, hydroxy, —NH 2 , —CN or —NO 2 ; or Q 2 ;

each R 8 is independently halogen, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 1 -C 6 alkylthio, C 1 -C 6 haloalkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkylsulfonyl, C 1 -C 6 alkylamino, C 2 -C 6 dialkylamino, C 2 -C 4 alkoxycarbonyl, —CN or —NO 2 ;

each R 9 is independently halogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 3 -C 6 cycloalkyl, C 3 -C 6 halocycloalkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 1 -C 6 alkylthio, C 1 -C 6 haloalkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkylsulfonyl, C 1 -C 6 alkylamino, C 2 -C 6 dialkylamino, —CN, —NO 2 , phenyl or pyridinyl;

R 10 is H; or C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C 4 -C 7 alkylcycloalkyl or C 4 -C 7 cycloalkylalkyl, each optionally substituted with one of more halogen;

R 11 is H, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C 4 -C 7 alkylcycloalkyl, C 4 -C 7 cycloalkylalkyl, C 2 -C 7 alkylcarbonyl or C 2 -C 7 alkoxycarbonyl;

R 12 is H; Q 3 ; or C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C 4 -C 7 alkylcycloalkyl or C 4 -C 7 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R 7 ; or

R 11 and R 12 are taken together with the nitrogen to which they are attached to form a ring containing 2 to 6 atoms of carbon and optionally one additional N, S or O atom, said ring optionally substituted with 1 to 4 substituents independently selected from the group consisting of C 1 -C 2 alkyl, halogen, —CN, —NO 2 and C 1 -C 2 alkoxy;

Q 1 is a phenyl ring, a 5- or 6-membered heterocyclic ring, or an 8-, 9- or 10-membered fused bicyclic ring system optionally containing one to three heteroatoms wherein said one to three heteroatoms comprise up to 1 O, up to 1 S and up to 3 N, each ring or ring system optionally substituted with one or more substituents independently selected from R 8 ;

each Q 2 is independently a phenyl ring or a 5- or 6-membered heterocyclic ring, each ring optionally substituted with one or more substituents independently selected from R 9 ;

Q 3 is a phenyl ring or a 5- or 6-membered heterocyclic ring, each ring optionally substituted with one or more substituents independently selected from R 9 ; and

n is 0, 1 or 2; and

b) a pharmaceutically acceptable carrier;

wherein the pharmaceutically acceptable carrier comprises:

i) a surfactant selected from the group consisting of polyethylene glycol stearates and polyethylene glycol hydroxystearates;

ii) one or more fillers,

iii) one or more binders; and

at least one humectant, solvent or lubricant, or combination thereof.

2. The method of claim 1 , wherein the isoxazoline active agent of Formula (I) is 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide.

3. The method of claim 1 , wherein the parasites are fleas or ticks.

4. The method of claim 1 , wherein:

W is O;

R 4 is H or C 1 -C 6 alkyl;

R 5 is —CH 2 C(O)NHCH 2 CF 3 ;

each of A 1 , A 2 , A 3 , A 4 , A 5 and A 6 is CH;

R 1 is C 1 -C 6 alkyl each optionally substituted with one or more substituents independently selected from R 6 ;

R 6 is halogen or C 1 -C 6 alkyl; and

B 1 , B 2 , and B 3 are independently CH, C-halogen, C—C 1 -C 6 alkyl, C—C 1 -C 6 haloalkyl, or C—C 1 -C 6 alkoxy.

5. The method of claim 1 , wherein:

W is O;

R 1 is CF 3 ;

B 2 is CH;

B 1 is C—Cl;

B 3 is C—Cl or C—CF 3 ;

each of A 1 , A 2 , A 3 , A 4 , A 5 and A 6 is CH;

R 4 is H; and

R 5 is —CH 2 C(O)NHCH 2 CF 3 .

6. The method of claim 1 , wherein the carrier further comprises at least one flavoring agent; and optionally an antioxidant, a preservative and/or disintegrant.

7. The method of claim 1 , wherein the one or more fillers are soy protein fines, corn starch, or a mixture thereof.

8. The method of claim 1 , wherein the binder is polyvinylpyrrolidone, a co-polymer of vinyl acetate and vinyl pyrrolidone or a polyethylene glycol, or a combination thereof.

9. The method of claim 1 , wherein the solvent is a liquid polyethylene glycol or a caprylic/capric triglyceride, or a combination thereof.

10. The method of claim 1 , wherein the humectant is glycerin or propylene glycol.

11. The method of claim 6 , wherein the flavoring agent is an artificial meat or beef flavor.

12. The method of claim 6 , wherein:

a) the filler is selected from the group consisting of corn starch, pre-gelatinized corn starch, corn gluten meal, soy protein fines, and a combination thereof;

b) the solvent is selected from the group consisting of liquid polyethylene glycols, propylene glycol, propylene carbonate, caprylic/capric triglycerides, caprylic/capric/linoleic triglycerides, caprylic/capric/succinic triglycerides, propylene glycol dicaprylate/dicaprate, glycerol caprylate/caprate, polyglycolized glycerides, and a combination thereof,

c) the binder is selected from the group consisting of polyvinylpyrrolidone, polyethylene glycols, co-polymers of vinyl acetate and vinylpyrrolidone, potato starch, corn starch, and a combination thereof;

d) the humectant is selected from the group consisting of glycerol, propylene glycol, cetyl alcohol, glycerin monostearate, polyethylene glycols, and a combination thereof; and

e) the surfactant is polyethylene glycol hydroxystearates

f) the flavoring agent is a natural or artificial beef or meat flavor.

13. The method of claim 12 , wherein the active agent of formula (I) is present at a concentration of about 1% to about 20% by weight.

14. The method of claim 13 , wherein:

a) the filler is a combination of corn starch and soy protein fines and is present at a concentration of about 30% to about 60% (w/w);

b) the solvent is a mixture of liquid polyethylene glycol and caprylic/capric triglycerides and is present at a concentration of about 5% to about 20% (w/w);

c) the binder is polyethylene glycol or polyvinylpyrrolidone, or a combination thereof, and is present at a concentration of about 5% to about 15% (w/w);

d) the humectant is glycerin and is present at a concentration of about 5% to about 20%;

e) the surfactant is a polyethylene glycol 12-hydroxystearate and is present at a concentration of about 1% to about 5% (w/w).

15. The method of claim 14 , wherein the active agent of Formula (I) is present at a concentration of about 1% to about 5% by weight.

16. The method of claim 14 , wherein the active agent of Formula (I) is present at a concentration of about 10% to about 20% by weight.

17. The method of claim 6 , wherein the soft chewable veterinary composition is selected from the group consisting of:

Ingredients

Function

% (w/w)

Cmpd. A

Active

 2.2

Soy Protein Fines

Filler

26.5 (QS)

Corn Starch

Filler

31.0

artificial meat flavor

Flavoring

 5.1

artificial beef flavor

Flavoring

 7.1

Povidone K-30

Binder

 2.8

PEG 400

Solvent

 7.1

PEG 4000

Binder

 6.4

polyethylene glycol 12-hydroxystearate

Surfactant

 3.0

Glycerin

Humectant

 5.1

Potassium Sorbate

Preservative

 0.3

Caprylic/capric triglyceride

Solvent/Lubricant

 3.2;

Ingredients

Function

% (w/w)

Cmpd. A

Active

1.5

Soy Protein Fines

Filler

46.5 (QS)

beef flavor

Flavoring

20.0

Povidone K-30

Binder

7.0

PEG 400

Solvent

15

polyethylene glycol 12-hydroxystearate

Surfactant

3.0

Caprylic/capric triglyceride

Solvent/lubricant

7.0;

Ingredients

Function

% (w/w)

Cmpd. A

Active

 1.875

Soy Protein Fines

Filler

46.1 (QS)

beef flavor

Flavoring

20.0

Povidone K-30

Binder

 8.5

PEG 400

Solvent

15.5

polyethylene glycol 12-hydroxystearate

Surfactant

 3.0

Caprylic/capric triglyceride

Solvent/lubricant

 5.0;

Ingredients

Function

% (w/w)

Cmpd. A

Active

 1.875

Soy Protein Fines

Filler

36.1 (QS)

beef flavor

Flavoring

20.0

Povidone K-30

Binder

 8.5

PEG 400

Solvent

15.5

polyethylene glycol 12-hydroxystearate

Surfactant

 3.0

Caprylic/capric triglyceride

Solvent/lubricant

 5.0

Croscarmellose sodium

disintegrant

10.0;

Ingredients

Function

% (w/w)

Cmpd. A

Active

 2.3

Soy Protein Fines

Filler

20.6 (QS)

Corn Starch

Filler

25.0

beef flavor

Flavoring

20.5

Povidone K-30

Binder

 2.8

PEG 400

Solvent

 7.2

PEG 4000

Binder

 6.4

polyethylene glycol 12-hydroxystearate

Surfactant

 3.1

Glycerin

Humectant

 8.6

Potassium Sorbate

Preservative

 0.3

Caprylic/capric triglyceride

Solvent/Lubricant

 3.1;

Ingredients

Function

% (w/w)

Cmpd. A

Active

 2.3

Soy Protein Fines

Filler

20.0 (QS)

Corn Starch

Filler

25.0

beef flavor

Flavoring

20.0

Povidone K-30

Binder

 2.8

PEG 400

Solvent

 7.1

PEG 4000

Binder

 6.4

polyethylene glycol 12-hydroxystearate

Surfactant

 3.1

Glycerin

Humectant

10.0

Potassium Sorbate

Preservative

 0.3

Caprylic/capric triglyceride

Solvent/Lubricant

 3.2;

Ingredients

Function

% (w/w)

Cmpd. A

Active

 0.5

Soy Protein Fines

Filler

16.6

Corn Starch

Filler

32.5 (QS)

beef flavor

Flavoring

19.4

Povidone K-30

Binder

 2.6

PEG 400

Solvent

 7.8

PEG 4000

Binder

 6.1

polyethylene glycol 12-hydroxystearate

Surfactant

 4.7

Lauroyl polyoxyl-32 glycerides

Surfactant

 4.7

Potassium Sorbate

Preservative

 0.3

Caprylic/capric triglyceride

Solvent/Lubricant

 4.9;

Ingredients

Function

% (w/w)

Cmpd. A

Active

 0.5

Soy Protein Fines

Filler

26.9 (QS)

Corn Starch

Filler

23.4

beef flavor

Flavoring

20.0

PEG 400

Solvent

 6.8

PEG 4000

Binder

 5.8

polyethylene glycol 12-hydroxystearate

Surfactant

 4.8

Lauroyl polyoxyl-32 glycerides

Surfactant

 6.3

Potassium Sorbate

Preservative

 0.3

Caprylic/capric triglyceride

Solvent/Lubricant

 5.2;

Ingredients

Function

% (w/w)

Cmpd. A

Active

 0.5

Soy Protein Fines

Filler

41.6 (QS)

beef flavor

Flavoring

19.9

Povidone K-30

Binder

 4.6

PEG 400

Solvent

15.1

PEG 4000

Binder

 8.1

polyethylene glycol 12-hydroxystearate

Surfactant

 4.6

Potassium Sorbate

Preservative

 0.3

Caprylic/capric triglyceride

Solvent/Lubricant

 4.6;

Ingredients

Function

% (w/w)

Cmpd. A

Active

 0.5

Corn Starch

Filler

 40.8 (QS)

beef flavor

Flavoring

19.9

Povidone K-30

Binder

 5.7

PEG 400

Solvent

11.4

PEG 4000

Binder

 5.7

polyethylene glycol 12-hydroxystearate

Surfactant

 2.7

Lauroyl polyoxyl-32 glycerides

Surfactant

 2.7

Potassium Sorbate

Preservative

 0.3

Caprylic/capric triglyceride

Solvent/Lubricant

 5.4

Sodium Starch glycolate

Disintegrant

 5.0;

Ingredients

Function

% (w/w)

Cmpd. A

Active

 0.5

Soy Protein Fines

Filler

19.4

Corn Starch

Filler

24.0 (QS)

beef flavor

Flavoring

19.2

Povidone K-30

Binder

 2.6

PEG 400

Solvent

 8.6

PEG 4000

Binder

 6.0

polyethylene glycol 12-hydroxystearate

Surfactant

 4.6

Lauroyl polyoxyl-32 glycerides

Surfactant

 4.6

Potassium Sorbate

Preservative

 0.3

Caprylic/capric triglyceride

Solvent/Lubricant

 5.3

Glycerin

Humectant

 4.8;

Ingredients

Function

% (w/w)

Cmpd. A

Active

 2.3

Soy Protein Fines

Filler

22.0 (QS)

Corn Starch

Filler

26.4

beef flavor

Flavoring

10.0

Artificial Powdered Meat Flavor

Flavoring

10.0

Povidone K-30

Binder

 2.7

PEG 400

Solvent

 7.0

PEG 4000

Binder

 6.25

polyethylene glycol 12-hydroxystearate

Surfactant

 3.0

Glycerin

Humectant

 7.0

Potassium Sorbate

Preservative

 0.3

Caprylic/capric triglyceride

Solvent/Lubricant

 3.0;

Ingredients

Function

% (w/w)

Cmpd. A

Active

13.6

Soy Protein Fines

Filler

15-25 (QS)

Corn Starch

Filler

15-25

beef flavor

Flavoring

20

PEG 400

Solvent

11.9

PEG 4000

Binder

 5

polyethylene glycol 12-hydroxystearate

Surfactant

 3-5

Glycerin

Humectant

 2-5

Potassium Sorbate

Preservative

 0.3;

Ingredients

Function

% (w/w)

Cmpd. A

Active

13.6

Soy Protein Fines

Filler

12.6

Corn Starch

Filler

25 (QS)

beef flavor

Flavoring

20

Povidone K-30

Binder

 2.75

PEG 400

Solvent

 5.5

PEG 4000

Binder

 6.2

polyethylene glycol 12-hydroxystearate

Surfactant

 5.0

Glycerin

Humectant

 7-8

Potassium Sorbate

Preservative

 0.3

Caprylic/capric triglyceride

Solvent/Lubricant

 2.0;

Ingredients

Function

% (w/w)

Cmpd. A

Active

13.6

Soy protein fines

Filler

15.2 (QS)

Corn Starch

Filler

25

beef flavor

Flavoring

20

PEG 400

Solvent

11.9

PEG 4000

Binder

 5.0

polyethylene glycol 12-hydroxystearate

Surfactant

 5.0

Caprylic/capric triglyceride

Solvent/lubricant

 1.0

Glycerin

Humectant

 3.0

Potassium Sorbate

Preservative

 0.3;

Ingredients

Function

% (w/w)

Cmpd. A

Active

13.6

Soy protein fines

Filler

19.2 (QS)

Corn Starch

Filler

20

beef flavor

Flavoring

20

PEG 400

Solvent

11.9

PEG 4000

Binder

 5.0

polyethylene glycol 12-hydroxystearate

Surfactant

 5.0

Caprylic/capric triglyceride

Solvent/lubricant

 1.0

Glycerin

Humectant

 4.0

Potassium Sorbate

Preservative

 0.3;

Ingredients

Function

% (w/w)

Cmpd. A

Active

13.6

Soy protein fines

Filler

24.2 (QS)

Corn Starch

Filler

15

beef flavor

Flavoring

20

PEG 400

Solvent

11.9

PEG 4000

Binder

 5.0

polyethylene glycol 12-hydroxystearate

Surfactant

 5.0

Caprylic/capric triglyceride

Solvent/lubricant

 1.0

Glycerin

Humectant

 4.0

Potassium Sorbate

Preservative

 0.3

wherein the Cmpd. A is 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide.

18. The method of claim 1 , wherein the surfactant is a polyethylene glycol 12-hydroxystearate.

19. The method of claim 1 , wherein the surfactant is polyethylene glycol 15 12-hydroxystearate.

20. The method of claim 14 , wherein the surfactant is polyethylene glycol 15 12-hydroxystearate.

21. The method of claim 14 , wherein the isoxazoline active agent of formula (I) is 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide.

22. The method of claim 12 , wherein the filler is corn starch or soy protein fines, or a combination thereof.

23. The method of claim 12 , wherein the solvent is liquid polyethylene glycols or caprylic/capric triglycerides, or a combination thereof.

24. The method of claim 12 , wherein the binder is polyvinylpyrrolidone, a co-polymer of vinyl acetate and vinylpyrrolidone or a polyethylene glycol, or a combination thereof.

25. The method of claim 12 , wherein the humectant is glycerol, propylene glycol, or a combination thereof.

26. The method of claim 12 , wherein:

the filler is corn starch or soy protein fines, or a combination thereof;

the binder is polyvinylpyrrolidone, a co-polymer of vinyl acetate and vinylpyrrolidone or polyethylene glycol, or a combination thereof; and

the humectant is glycerol, propylene glycol, or a combination thereof.

27. The method of claim 12 , wherein:

a) the filler is a combination of corn starch and soy protein fines;

b) the solvent is liquid polyethylene glycols or caprylic/capric triglycerides, or a combination thereof;

c) the binder is polyvinylpyrrolidone or polyethylene glycol; and

d) the humectant is glycerol.

28. The method of claim 26 or 27 , wherein the isoxazoline active agent of formula (I) is 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide.

29. The method of claim 14 , wherein:

a) the filler is present at a concentration of about 35% to about 55% (w/w);

b) the solvent is present at a concentration of about 5% to about 15% (w/w);

c) the binder is present at a concentration of about 5% to about 10% (w/w); and

d) the humectant is present at a concentration of about 5% to about 15% (w/w).

30. The method of claim 29 , wherein the isoxazoline active agent of formula (I) is 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 2, 2020
From: MERIAL, INC.
To: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Reel/Frame 051459/0819 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2016
From: SOLL, MARK DAVID; LARSEN, DIANE; CADY, SUSAN MANCINI; CHEIFETZ, PETER; GALESKA, IZABELA; GONG, SAIJUN
To: MERIAL LIMITED
Reel/Frame 038312/0952 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2016
From: MERIAL LIMITED
To: MERIAL, INC.
Reel/Frame 038463/0418 →
Continuity (3)
Division 13754969 · Jan 31, 2013
Provisional Application 61595463 · Feb 6, 2012
Related Publication 20160374994A1 · Dec 29, 2016